OBJECTIVE: To compare the efficacy and safety of China made gene recombined Streptokinase(rSK)and German made streptokinase(SK)in the treatment of acute myocardial infarction(AMI).

• 对比分析国产基因重组链激酶和德国链激酶静脉溶栓治疗急性心肌梗塞（AMI）的有效性和安全性。